hyperactivated NP394-neurons showed promoted light avoidance, we propose that NP394-neuron activity is positively correlated with larval lightavoidance ability. Two possible scenarios could be operating in this situation. First, the activity of NP394-neurons itself controls the larval phototaxis by an unknown mechanism. Second, the NP394-neurons activate the pathway that mediates avoidance of light whereas other unidentified neurons activate the pathway that underlies avoidance of darkness, as was shown for the mechanisms underlying odor-taxis in adult Drosophila (25). Here, we used a titration approach to answer this question in intact, cultured chromaffin cells. Simultaneous expression of wild-type SNAP-25 and a mutant unable to support exocytosis progressively altered fusion kinetics and fusion-pore opening, indicating that both proteins assemble into heteromeric fusion complexes. Expressing different wild-type:mutant ratios revealed a third-power relation for fast (synchronous) fusion and a near-linear relation for overall release. Thus, fast fusion typically observed in synapses and neurosecretory cells requires at least three functional SNARE complexes, whereas slower release might occur with fewer complexes. Heterogeneity in SNARE-complex number may explain heterogeneity in vesicular release probability.
T he SNARE [soluble N-ethylmaleimidesensitive factor attachment protein (SNAP) receptor] complex formed between two fusing membranes is at the heart of the molecular machinery that mediates exocytosis (1) . It is a coiled bundle of four parallel a helices provided by three SNARE proteins: SNAP-25 (synaptosomeassociated protein of 25 kD), synaptobrevin-2, and syntaxin-1 (2) . SNARE-complex formation proceeds from the N-to the C-terminal end in a discontinuous process that involves partially assembled intermediates. Assembly of the most Cterminal three to four interaction layers coincides with membrane merger (3) . Though it has been unclear whether assembly of one SNARE complex generates sufficient energy to initiate vesicle fusion (4) (5) (6) (7) , it was recently reported that liposomes can fuse with the help of a single SNARE complex, albeit with low speed (8) . Other studies have concluded that 5 to 11 SNARE complexes might be involved in faster modes of fusion (9) (10) (11) (12) (13) .
To study the dependence of fast vesicle fusion on higher-order SNARE complexes in intact cells, we used an exceptionally inhibitory SNAP-25 mutation in a titration assay that allowed us to relate exocytosis to the relative expression levels of mutant and wild-type (WT) protein in a given cell. Our mutant harbored two alanine substitutions [Met 71 → Ala 71 (M71A) and Ile 92 → Ala 92 (I192A)] in the interaction layer +5, facing the inside of the complex (2) . If incorporated in the SNAP-25A isoform, this mutation completely fails to reconstitute exocytosis in Snap-25 -/-adrenal chromaffin cells (14) . Here, we introduced the mutation into SNAP-25B, because this isoform supports two to three times more fast-phase secretion (15) . SNAP-25B WT (SN25B) or mutant protein (denoted SN25BL5**) were N-terminally fused to enhanced green fluorescent protein (EGFP) or mCherry (mCh), allowing for the quantitative analysis of expression levels and protein localization.
Using the Semliki Forest virus (SFV) expression system, we characterized mCh-tagged SN25BL5** and mCh-SN25B expressed separately in SNAP-25-deficient chromaffin cells (16) . Both proteins were localized to the plasma membrane and expressed to similar levels ( Fig. 1 , E and F). Secretion was assayed by membrane capacitance measurements and amperometry after flash photorelease of caged calcium. Expression of mCh-SN25BL5** suppressed secretion (total capacitance change: 12 T 3 fF after 5 s; n = 28 cells) ( Fig. 1 , A to E) compared with mCh-SN25B-infected cells (510 T 54 fF; n = 36; P < 0.0001) and even SNAP-25-deficient cells (39 T 5 fF; n = 35; P < 0.0001; Student's t test). This made SN25BL5** an attractive inhibitor for a titration experiment. Several lines of evidence indicate that inhibition probably arises from interference with a very late step of exocytosis associated with the C-terminal assembly of the SNARE complex: (i) SN25L5** forms stable SNARE complexes in vitro, exhibiting assembly kinetics indistinguishable from WT protein (14) . However, mutant SNARE complexes exhibit a strongly destabilized C-terminal end (14) . (ii) SNAP-25 is required for vesicle docking (17) before participating in downstream steps of exocytosis. Expression of SN25BL5** completely restored docking in Snap-25 -/-cells ( Fig. 1, G to I, and fig. S1 ), excluding an involvement of layer +5 in these early steps of exocytosis. (iii) The phenotypes caused by single point mutations in layer +5 of SN25B (M71A or I192A) indicate that assembly of this layer is important for fusion triggering. Expression of either mutant in Snap-25 -/-cells slowed down fusion kinetics ( fig. S2, A and B) , similar to other mutations compromising the C-terminal end of the SNARE complex (14, 18) . In contrast, unchanged sustained-release rates (fig. S2Ab and S2Bb) and normal recovery between stimulations (fig. S2Ae and S2Be) suggest normal vesicle priming.
To obtain cells with varying ratios of mCh-SN25BL5** and EGFP-SN25B, we generated viruses harboring bicistronic expression units containing different "internal ribosome entry site" (IRES)-sequences ( fig. S3) (16) . After calibration with an EGFP-mCh fusion protein ( fig. S3B ), relative expression levels of the two fusion proteins were assessed by quantifying mCh and EGFP fluorescence. All viruses displayed substantial variations of expression ratios in individual cells, which were exploited to cover a wider range of expression ratios. The two fusion proteins colocalized closely ( fig. S4 ), both on the plasma membrane and on certain intracellular structures (19) .
In control recordings, EGFP-SN25B-expressing cells exhibited an average total capacitance increase of 483 T 25 fF (n = 125). Progressively increasing fractional mCh-SN25BL5** expression had a mild inhibitory effect on overall exocytosis ( Fig. 2A) . The inhibition profile was well described by a linear dependency on the fraction of mCh-SN25BL5**. Kinetic analysis revealed a progressive slowdown of release kinetics (Fig.  2B ), owing to a gradual increase of fast-and slowburst time constants (Fig. 2 , C and D) combined with decreased amplitude of the fast component (Fig. 2E ). For cells expressing low levels of mCh-SN25BL5** (0 to 20%, group I), the decrease in fast-release amplitude was partly compensated for by an increase in slow-burst amplitude (Fig. 2F ) and in the rate of sustained secretion (Fig. 2G) . Overall, vesicles fuse at lower rates in the presence of SN25BL5**, implying that the vesicular release probability is decreased. Because exocytosis cannot be mediated by fusion complexes solely containing SN25BL5**, this finding indicates the formation of mixed fusion complexes containing both EGFP-SN25B and mCh-SN25BL5**.
Formation of mixed fusion complexes was also supported by experiments examining singlevesicle fusion events (Fig. 3) . In these experiments, Snap-25 -/-cells were infected with a SFV expressing~80% mCh-SN25BL5** and~20% EGFP-SN25B ( fig. S3D ). In the presence of mCh-SN25BL5**, amperometric spikes exhibited a slightly delayed overall waveform and a decreased duration of pre-spike feet (PSF). Because mCh-SN25BL5** cannot support exocytosis on its own, these data indicate single-vesicle fusion using mixed complexes. A similar reduction in PSF duration has been described upon mutating the C-terminal layers of synaptobrevin-2 (18) .
The above findings suggested that multiple SNARE complexes might surround the nascent fusion pore (12) . Thus, we asked how many SNARE complexes are needed for fast vesicle fusion. Assuming that the incorporation of one copy of SN25BL5** is sufficient to decrease the vesicular release rate, vesicle fusion with normal fast kinetics should be mediated by complexes containing exclusively WT SN25B. The number of such vesicles depends on the fractional availability of WT SN25B raised to a power of n, where n is the number of SN25B molecules in the fusion complex (20) . To determine the amount of fusion with unperturbed kinetics, we repeated the kinetic analysis, but this time we fixed the fast time constant t fast to the control value (EGFP-SN25B, t fast = 19.8 ms), such that the amplitude reports unperturbed secretion. The number of fast-fusing vesicles diminished much faster than overall secretion with an increasing proportion of mCh-SN25BL5** (Fig. 4A , compare with Fig. 2A ). Fitting of a simple binomial model (21) to the entire curve identified n = 2.8. Alternatively, we fitted a straight line to the left part of the curve, following logarithmic transform of the burst am- The half width was slightly prolonged in the presence of SN25BL5** (P < 0.05). The pre-spike foot duration and charge were reduced, indicating altered fusion-pore opening (**P < 0.01 and ***P < 0.001; Student's t test). (21), which yielded n = 3.4 (inset, Fig. 4A ). Our model assumes that the affinity of SN25BL5** to the rest of the fusion apparatus is unchanged, which appears likely from previous data (14) . Three is a lower estimate of the number of SNARE complexes in a fusion complex driving fast fusion, because incorporation of more than one mutant might be required to detectably change fusion kinetics.
SNAP-25 harbors two SNARE domains and could possibly contribute these to different SNARE complexes, thereby cross-linking them (21, 22) . This would separate the two single mutations and mask a dominant-negative effect of SN25BL5** in the presence of WT protein ( fig. S5A ), which could provide an alternative explanation for the shallow dependence of overall secretion on SN25BL5** fraction ( Fig. 2A) . We tested such "domain-swapping" by coexpression of the two single-layer +5 mutants (M71A and I192A). At similar expression levels, the two single alanines should recreate the catastrophic double-layer +5 mutation in half of the complexes ( fig. S5B ), which should result in a 50% drop in secretion (Fig. 4B , according to Fig. 2A ). Using two bicistronic SFVs that express both mutants at the proportions [mCh-SN25M71A]/total of 15 T 1% or 65 T 3%, we observed no inhibitory effect on secretion (Fig. 4C ). In addition, examining data in 20-to-50% or 50-to-80% expression bins did not identify any block of release (Fig. 4C) . Thus, domain-swapping cannot explain the mild inhibition by SN25BL5**, nor can it represent a prominent event during exocytosis, consistent with the finding that separated SNAP-25 SNARE domains support in vitro vesicle fusion (23) and secretion (24).
Using a titration approach in intact cells, we report here that the apparent cooperativity for fastphase secretion is higher (~3) than that for overall exocytosis (~1). We conclude that SNARE complexes form higher-order functional units, and at least three SNARE complexes are required for the fast phase of exocytosis ( fig. S5, C and D) . Our findings agree with data from infusion of synaptobrevin fragments into PC12 cells (11) . The linear titration profile of overall secretion might be explained if stoichiometry of fusion complexes is not fixed. Vesicles resident at the plasma membrane have time to form several SNARE complexes in the absence of stimulation, achieving faster speeds of fusion when triggered by calcium. However, vesicles arriving during conditions of sustained high calcium concentrations might fuse using fewer [or possibly only a single (8) ] SNARE complexes. The dramatic shift in release rate upon coexpression of SN25BL5** suggests that the number of functional (that is, completely zippering) SNARE complexes is a determinant of fusion probability. Indeed, variable fusion stoichiometry might underlie heterogeneity in vesicular release probabilities between synapses (25) or release phases (26) and could represent an important regulated parameter in neurotransmitterreleasing cells. The M2 protein of influenza viruses forms an acid-activated tetrameric proton channel. We used solid-state nuclear magnetic resonance spectroscopy to determine the structure and functional dynamics of the pH-sensing and proton-selective histidine-37 in M2 bound to a cholesterol-containing virus-envelope-mimetic membrane so as to better understand the proton conduction mechanism. In the high-pH closed state, the four histidines form an edge-face p-stacked structure, preventing the formation of a hydrogen-bonded water chain to conduct protons. In the low-pH conducting state, the imidazoliums hydrogen-bond extensively with water and undergo microsecond ring reorientations with an energy barrier greater than 59 kilojoules per mole. This barrier is consistent with the temperature dependence of proton conductivity, suggesting that histidine-37 dynamically shuttles protons into the virion. We propose a proton conduction mechanism in which ring-flip-assisted imidazole deprotonation is the rate-limiting step.
P roton transport in synthetic materials is mediated either solely by hydrogen-bonded (H-bonded) water, as in hydrated ionic polymers (1), or solely by titratable heterocycles, such as imidazoles tethered to the backbone of anhydrous polymers (2) . In comparison, the conduction mechanism of biological proton channels in cell membranes is more complex because both water and titratable protein sidechains are usually present (3). The influenza M2 protein forms a tetrameric proton channel that is important for the virus life cycle (4) . Activated below pH 6, the M2 channel conducts 10 to 10,000 protons per second (5, 6). The pH-sensing and proton-selective residue is a single histidine, His37, in the trans- 
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Materials and methods
Chromaffin cell preparation and viral expression system. Snap-25 null embryos were obtained by Cesarean section at E17-E18. Preparation of adrenal glands and cultivation of chromaffin cells were performed as described before (S1). Plasmids needed for generation of Semliki Forest viruses were generated by standard techniques of molecular biology. Starting from a cDNA encoding an N-terminal fusion construct between SNAP-25 and EGFP (S2) (here denoted EGFP-SN25B), we generated GFP-SN25B variants with either single (M71A or I192A) or double alanine substitutions in layer +5 by PCR mutagenesis. The generated PCR-fragments were cloned into a modified pSFV1 plasmid containing a multiple cloning site with unique Nsi I and BssH II restriction sites (courtesy of Ralf B. Nehring). To obtain mCherry-tagged versions of these SNAP-25 variants, appropriate PCR fragments of mCherry (S3) (mCh; kind gift of Dr. Roger Tsien) and mutated SN25B were generated, fused by PCR, and cloned into pSFV1 plasmid. Bicistronic expression units were constructed by fusing PCR-fragments of the polio virus-IRES sequence or the CITE-IRES sequence to PCR-fragments containing EGFP-SN25B or mCherry-SN25B M71A, I192A. The polio virus IRES sequence was adapted from an existing SFV transfer vector previously generated in our lab (S4). The EMCV IRES sequence was taken from pCITE2a (Novagen/Merck, Nottingham, UK) and further modified according to (S5) to yield attenuated versions. In an initial step of the cloning strategy we generated a fused PCR product containing the appropriate IRES sequence and the second open-reading frame either containing EGFP-SN25B or mCh-SN25BL5**. Care was taken to place the start-codon of the sequence at the right position with respect to the end of the IRES sequence. Due to a lack of restriction sites the generated PCR product was then fused to a fragment covering the downstream sequence of pSFV1 up to the unique Spe I site. The resulting PCR product was finally inserted back into pSFV1 using the restriction sites BssH II and Spe I. In a second step an additional PCR fragment containing the sequence of the appropriate first open reading frame was generated and cloned into the modified pSFV1 vector using the restriction sites Nsi I and BssH II. All constructs were thoroughly sequenced before production of SFV particles. For experiments stored virus aliquots were activated by chymotrypsin cleavage, chymotrypsin was inactivated with aprotinin, and chromaffin cells were infected at days 2-4 after isolation. Electrophysiological recordings were performed at room temperature 5-8 h after infection with viruses. Electrophysiology, electrochemistry, and calcium imaging. Flash photolysis of caged calcium, ratiometric measurements of intracellular calcium concentration, patch-clamp capacitance measurements, and amperometric recordings were performed as previously described (S1, S7).
Expression assays by Western blot and fluorescence intensity. The expression of tagged SNAP-25 variants after infection with bicistronic Semliki Forest viruses (SFV) was analyzed by
Secretion was elicited by flash photorelease of caged calcium and monitored in parallel by capacitance measurements and amperometric recordings, which ensured that mainly catecholamine release from dense-core vesicles was studied. To eliminate photo-artifacts from amperometric traces originating from the UV flash light, isolated artifacts were recorded after removal of the chromaffin cell using the patch pipette and subsequently subtracted from associated traces. Nitrophenyl-EGTA (NPE) used in calcium-uncaging experiments was obtained from Synaptic Systems (Göttingen, Germany). Microimaging GmbH). Detector gains of both channels were individually adjusted to cover the whole intensity range. Eight frames were taken in each channel in an alternating fashion and averaged to yield the final image. Only cells with moderate expression of both SNAP-25 variants were selected for analysis, as overly high expression levels lead to an almost homogenous protein distribution in cells.
Image analysis was performed with ImageJ software. Using the popular "Just Another Colocalisation Plugin" (JACoP; (S8)) we analyzed the extent of colocalization between mCh-SN25BL5** and EGFP-SN25B. As reference we used the EGFP-mCh fusion protein, which by definition is expected to produce highly colocalized fluorescence signals. Crosstalk between channels under these experimental conditions was tested by imaging cells solely expressing EGFP or mCh-tagged SNAP-25. Using fixed gain settings for both detector channels we found 4.1±0.9% (n=18) crosstalk for EGFP in the mChchannel and 1.1±0.2% (n=18) crosstalk for mCh in the EGFP-channel, respectively. Note that crosstalk of EGFP in the mCh-channel was likely overestimated in this control experiment due to the gain settings that favored the red channel over the green as well as due to the occurrence of background fluorescence.
Amperometric spikes. Amperometric spikes were recorded as previously described (S1). While amperometric recordings were performed with carbon fibers of 10 µm (Amoco Corp., Greenville, SC) during flash-photolysis experiments, we employed fibers of 5 µm diameter for recordings of single spikes in order to reduce noise. Due to a rapid ageing of the amperometric electrodes, we used freshly prepared fibers for no more than two consecutive recordings. Fibers were clamped to +720mV, and amperometric current signals were amplified and prefiltered at 3 kHz using an EPC-7 (HEKA Elektronik, Lambrecht/Pfalz, Germany). For further analysis current traces were digitally filtered at 600 Hz (Gaussian filter) in Igor Pro. Amperometric spikes were detected (threshold 5pA) and analyzed with regard to amplitude, rise-time, halfwidth, and pre-spike foot duration/charge using a custom macro running in Igor Pro. To account for the significant cell-to-cell variability of amperometric data, and the fact that parameters are often not normally distributed, we relied on the cell median instead of the mean for our analysis. The medians of the waveform parameters were determined for each individual cell based on all recorded spikes, and the calculated medians were subsequently averaged within the experimental group and statistically compared. To ensure a sound estimation of the median only recordings with at least ten spikes were included in the analysis. 
Supporting text The rosette model of SNARE-complexes
We wish to arrive at a mathematical expression for the expected secretion when two different SNARE species are incorporated into a rosette-like fusion complex driving secretion, and to establish a way to determine n, the number of SNARE-complexes in a rosette. We further assume that S 0 and S 1 forms compete for forming individual SNARE-complexes, and that they have affinity K towards some acceptor complex A.
We assume that a functional release apparatus is made up of n SNARE-complexes, possibly arranged in a rosette-like manner, and that AS 0 and AS 1 participate in such rosettes in proportion to their abundance. Then, the probability P 0 and P 1 that a given slot is filled with wildtype and mutant forms of SNARE-complexes, respectively, can be calculated according to
Thus, P 0 is equal to the mole fraction of the mutant. The probability P n that all of the n SNARE complexes in the rosette are occupied by S 1 (or else, that the complex is fully functional and displays wildtype kinetics):
If the amplitude of the response Y (or else the amplitude of the component with wildtype kinetics) is assumed to be proportional to P n , then ( )
In this case, the slope of a plot of log Y versus x is:
which for x<<1 reduces to -n.
For differential affinities of species S o and S 1 towards the acceptor complex A, with α representing the ratio of affinity constants, a similar derivation yields -nα for the limiting slope in such a plot.
Thus the stoichiometry of the rosette (n) can be found by plotting the logarithm of the response size against x, the mol fraction of the mutation. The slope of the plot at low x-values will be -n scaled by the relative affinities of the two SNARE species towards the assumed receptor A. In case the mutant SNARE-form (with concentration S o ) is not an absolute dominant-negative, such that secretion is still possible when one or more mutants are incorporated into the rosette, estimation of n is still possible using the same expressions, if the amplitude of unperturbed secretion can be identified and used in the place of Y (for instance if incorporation of one mutant molecule results in a detectable kinetic change of secretion). 
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